Глава 6. Себорейный дерматит

Список литературы

Шеклакова М.Н. Оценка эффективности применения нового препарата пиритиона цинка Цинокап® в терапии больных себорейным дерматитом // Вестник дерматологии и венерологии. 2010. Т. 86. № 3. С. 49–55. eLIBRARY ID: 15131483.

Abbas Z., Ghodsi S.Z., Abedeni R. Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial // Dermatol. Pract. Concept. 2016. Vol. 6. N. 3. P. 11–16. DOI: https://doi.org/10.5826/dpc.0603a04. PMID: 27648378; PMCID: PMC5006547.

Apasrawirote W., Udompataikul M., Rattanamongkolgul S. Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis // J. Med. Assoc. Thai. 2011. Vol. 94. N. 6. P. 756–760. PMID: 21696088.

Barba A., Piubello W., Vantini I. et al. Skin lesions in chronic alcoholic pancreatitis // Dermatologica. 1982. Vol. 164. N. 5. P. 322–326. DOI: https://doi.org/10.1159/000250109. PMID: 6212271.

Bukvić Mokos Z., Kralj M., Basta-Juzbašić A., Lakoš Jukić I. Seborrheic dermatitis: an update // Acta Dermatovenerol. Croat. 2012. Vol. 20. N. 2. P. 98–104. PMID: 22726283.

Chattopadhyay S.P., Arora P.N., Anand S., Sharma S.D. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses // Indian J. Dermatol. 1987. Vol. 32. N. 2. P. 41–44. PMID: 3453353.

Chatzikokkinou P., Sotiropoulos K., Katoulis A. et al. Seborrheic dermatitis — an early and common skin manifestation in HIV patients // Acta Dermatovenerol. Croat. 2008. Vol. 16. N. 4. P. 226–230. PMID: 19111149.

Choeng W.K., Yeung C.K., Torsekar R.G. et al. Treatment of seborrhoeic dermatitis in Asia: a consensus guide // Skin Appendage Disord. 2015. Vol. 1. N. 4. P. 187–196. DOI: https://doi.org/10.1159/000444682. Epub 2016 Mar 23. PMID: 27386464; PMCID: PMC4908450.

Cicek D., Kandi B., Bakar S., Turgut D. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study // J. Dermatolog. Treat. 2009. Vol. 20. N. 6. P. 344–349. DOI:  https://doi.org/10.3109/09546630802687349. PMID: 19954391.

Clark G.W., Pope S.M., Jaboori K.A. Diagnosis and treatment of seborrheic dermatitis // Am. Fam. Physician. 2015. Vol. 91. N. 3. P. 185–190. PMID: 25822272.

Cömert A., Bekiroglu N., Gürbüz O., Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study // Am. J. Clin. Dermatol. 2007. Vol. 8. N. 4. P. 235–238. DOI:  https://doi.org/10.2165/00128071-200708040-00005. PMID: 17645378.

Cribier B., Samain F., Vetter D. et al. Systematic cutaneous examination in hepatitis C virus infected patients // Acta Derm. Venereol. 1998. Vol. 78. N. 5. P. 355–357. DOI:  https://doi.org/10.1080/000155598443051. PMID: 9779254.

Danby F.W., Maddin W.S., Margesson L.J., Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff // J. Am. Acad. Dermatol. 1993. Vol. 29. N. 6. P. 1008–1012. DOI:  https://doi.org/10.1016/0190-9622(93)70282-x. PMID: 8245236.

Davies D.B., Boorman G.C., Shuttleworth D. Comparative efficacy of shampoos containing coal tar (4.0% w/w; Tarmed™), coal tar (4.0% w/w) plus ciclopirox olamine (1.0% w/w; Tarmed™ AF) and ketoconazole (2.0% w/w; Nizoral™) for the treatment of dandruff/seborrhoeic dermatitis // J. Dermatolog. Treat. 1999. Vol. 10. N. 3. P. 177–183. DOI: https://doi.org/10.3109/09546639909056025. Epub 2009 Jul 12.

Elish D., Silverberg N.B. Infantile seborrheic dermatitis // Cutis. 2006. Vol. 77. N. 5. P. 297–300. PMID: 16776285.

Ficicioglu S., Piskin S. Dermoscopic findings in psoriasis and seborrheic dermatitis on the scalp and correlation with disease severity // Med. Sci. 2018. Vol. 7. N. 1. P. 118–121. DOI: https://doi.org/10.5455/medscience.2017.06.8731.

Ghodsi S.Z., Abbas Z., Abedeni R. Efficacy of oral itraconazole in the treatment and relapse prevention of moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial // Am. J. Clin. Dermatol. 2015. Vol. 16. N. 5. P. 431–437. DOI: https://doi.org/10.1007/s40257-015-0133-9. Epub 2015 May 28. PMID: 26016699.

Gilbertson K., Jarrett R., Bayliss S.J., Berk D.R. Scalp discoloration from selenium sulfide shampoo: a case series and review of the literature // Pediatr. Dermatol. 2012. Vol. 29. N. 1. P. 84–88. DOI: https://doi.org/10.1111/j.1525-1470.2011.01410.x. Epub 2011 Mar 31. PMID: 21453309.

Goldust M., Rezaee E., Rouhani S. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis // Ann. Parasitol. 2013. Vol. 59. N. 1. P. 25–29. PMID: 23829055.

Gupta A.K., Bluhm R. Seborrheic dermatitis // J. Eur. Acad. Dermatol. Venereol. 2004. Vol. 18. N. 1. P. 13–26. DOI: https://doi.org/10.1111/j.1468-3083.2004.00693.x. MID: 14678527.

Gupta A.K., Richardson M., Paquet M. Systematic review of oral treatments for seborrheic dermatitis // J. Eur. Acad. Dermatol. Venereol. 2014. Vol. 28. N. 1. P. 16–26. DOI: https://doi.org/10.1111/jdv.12197. Epub 2013 Jun 26. PMID: 23802806.

Gupta A.K., Versteeg S.G. Topical treatment of facial seborrheic dermatitis: a systematic review // Am. J. Clin. Dermatol. 2017. Vol. 18. N. 2. P. 193–213. DOI: https://doi.org/10.1007/s40257-016-0232-2. Epub 2016 Nov 02. PMID: 27804089.

Hald M., Arendrup M.C., Svejgaard E.L. et al. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases // Acta Derm. Venereol. 2015. Vol. 95. N. 1. P. 12–19. DOI: https://doi.org/10.2340/00015555-1825. PMID: 24556907.

Howard R. Leiner’s syndrome: erythroderma, diarrhea, and failure to thrive // Curr. Probl. Dermatol. 2000. Vol. 12. Issue 4. P. 183–185.

Kastarinen H., Oksanen T., Okokon E.O. et al. Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp // Cochrane Database Syst. Rev. 2014. Issue 5. DOI: https://doi.org/10.1002/14651858.CD009446.pub2. PMID: 24838779; PMCID: PMC6483543.

Kibar M., Aktan Ş., Bilgin M. Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair // Indian J. Dermatol. 2015. Vol. 60. N. 1. P. 41–45. DOI: https://doi.org/10.4103/0019-5154.147786. PMID: 25657395; PMCID: PMC4318061.

Kim G.-W., Jung H.-J., Ko H.-C. et al. Dermoscopy can be useful in differentiating scalp psoriasis from seborrheic dermatitis // Br. J. Dermatol. 2011. Vol. 164. N. 3. P. 652–656. DOI: https://doi.org/10.1111/j.1365-2133.2010.10180.x. Epub 2011 Feb 17. PMID: 21155753.

Kim T.-W., Mun J.-H., Jwa S.-W. et al. Proactive treatment of adult facial seborrheic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-center trial // Acta Derm. Venereol. 2013. Vol. 93. N. 5. P. 557–561. DOI: https://doi.org/10.2340/00015555-1532. PMID: 23388687.

Manriquez J.J., Uribe P. Seborrhoeic dermatitis // BMJ Clin. Evid. 2007. 2007; 1713. PMID: 19454093; PMCID: PMC2943817.

Medansky R., Lepaw M., Shavin J. et al. Mometasone furoate cream 0.1% vs. hydrocortisone cream 1% in the treatment of seborrhoeic dermatitis // J. Dermatolog. Treat. 1992. Vol. 3. N. 3. P. 125–128. DOI: https://doi.org/10.3109/09546639209088705.

Milani M., Di Molfetta S.A., Gramazio R. et al. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients // Curr. Med. Res. Opin. 2003. Vol. 19. N. 4. P. 342–345. DOI: https://doi.org/10.1185/030079903125001875. PMID: 12841928.

Nobles T., Krishnamurthy K. Cradle Cap // StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing, 2024 Jan. 2023 Aug 7. https://pubmed.ncbi.nlm.nih.gov/30285358/.

Nolting S., Hagemeier H.H. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution] // Fortschr. Med. 1983. Vol. 101. N. 37. P. 1679–1683. PMID: 6227542. (In German).

Okokon E.O., Verbeek J.H., Ruotsalainen J.H. et al. Topical antifungals for seborrhoeic dermatitis // Cochrane Database Syst. Rev. 2015. Issue 4. DOI: https://doi.org/10.1002/14651858.CD008138.pub3. PMID: 25933684; PMCID: PMC4448221.

Opdyke D.L., Burnett C.M., Brauer E.W. Anti-seborrhoeic qualities of zinc pyrithione in a cream vehicle. II. Safety evaluation // Food Cosmet. Toxicol. 1967. Vol. 5. N. 3. P. 321–326. DOI: https://doi.org/10.1016/s0015-6264(67)83057-8. PMID: 4228290.

Ortonne J.-P., Nikkels A.F., Reich K. et al. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study // Br. J. Dermatol. 2011. Vol. 165. N. 1. P. 171–176. DOI: https://doi.org/10.1111/j.1365-2133.2011.10269.x. MID: 21707573.

Papp K.A., Papp A., Dahmer B., Clark C.S. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults // J. Am. Acad. Dermatol. 2012. Vol. 67. N. (1). P. e11–e15. DOI: https://doi.org/10.1016/j.jaad.2011.02.032. Epub 2011 Nov 21. PMID: 22101215.

Park J.-H., Park Y.J., Kim S.K. et al. Histopathological differential diagnosis of psoriasis and seborrheic dermatitis of the scalp // Ann. Dermatol. 2016. Vol. 28. N. 4. P. 427–432. DOI: https://doi.org/10.5021/ad.2016.28.4.427. PMID: 27489423; PMCID: PMC4969470.

Piérard-Franchimont C., Goffin V., Decroix J., Piérard G.E. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis // Skin Pharmacol. Appl. Skin Physiol. 2002. Vol. 15. N. 6. P. 434–441. DOI: https://doi.org/10.1159/000066452. PMID: 12476017.

Pirkhammer D., Seeber A., Hönigsmann H., Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis // Br. J. Dermatol. 2000. Vol. 143. N. 5. P. 964–968. DOI: https://doi.org/10.1046/j.1365-2133.2000.03828.x. PMID: 11069503.

Ratnavel R.C., Squire R.A., Boorman G.C. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis // J. Dermatolog. Treat. 2007. Vol. 18. N. 2. P. 88–96. DOI: https://doi.org/10.1080/16537150601092944. PMID: 17520465.

Rigopoulos D., Ioannides D., Kalogeromitros D. et al. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial // Br. J. Dermatol. 2004. Vol. 151. N. 5. P. 1071–1075. DOI: https://doi.org/10.1111/j.1365-2133.2004.06208.x. PMID: 15541087.